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indicators were selected based on literature review and concept-focused group. Also, 
experts’ opinions considered for scoring these indicators. These indicators were 
weighted by Stepwise Adoption of Weights and were used to develop a model for 
measuring SES. Results: Five indicators were selected for determining SES of indi-
viduals. These indicators include income, occupation, education, home status and 
family size. A model for income classification based on city poverty line (CPL) was 
established.  The experts’ opinions were integrated in order to reach a degree of con-
sensus on the given scores to different occupation groups. A model for home status 
ranking based on national minimum wage (NMW) was introduced. A single model 
was developed to score homeowners and tenants at the same time. ConClusions: 
Four important findings emerged from this study. These include: 1. the average 
weight and the percentage of the impact of each socioeconomic indicator on the 
socioeconomic status of individuals are suggested. 2. A model based on CPL is intro-
duced for income classification. 3. A model based on NMW is developed for rent 
ranking. 4. A single model is accomplished for comparing homeowners and tenants. 
These findings may help researchers to apply a single model for determining SES, by 
which the results of various studies could be compared more directly; particularly 
in middle-income countries.
ReseaRch on Methods – Patient-Reported outcomes studies
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objeCtives: The aim of this study was to translate and construct the Chinese 
version of the eight-item Morisky Medication Adherence Scale (MMAS-8) among 
Taiwanese patients with hypertension. Methods: 604 outpatients with estab-
lished chronic hypertension at a regional hospital in eastern Taiwan were enrolled. 
Using a cross-sectional study, blood pressure (BP) was measured for and struc-
tured questionnaires were answered by all participants. Standard forward and 
backward translation, proofreading and joint discussion procedures were used 
to translate the MMAS-8. Internal consistency was assessed using Cronbach’sα 
coefficient, construct validity using factor analyses, and concurrent validity using 
correlation analysis. All data were analyzed using SPSS 20.0 statistical analysis 
software. Results: The mean of MMAS-8 scores was 2.6. Adherence and poor 
adherence of patients accounted for 57.5% and 42.5%, respectively. Cronbach’s α 
was found to be 0.83 (0.81-0.85) with 95% CI. Factor analysis was found R2 (46%), and 
all factor loadings of the MMAS-8 was greater than 0.30. Adherence was positively 
correlated with attitude (r= 0.24, p= 0 .00), subjective norm (r= 0.33, p= 0 .00), per-
ceived behavior control (r= 0.51, p= 0 .00), and intention (r= 0.49, p= 0 .00). Adherence 
was positively correlated with the SBP (r= 0.11, p= 0 .01), DBP (r= 0.16, p= 0 .00) and 
the MAP (r= 0.15, p= 0.00). When SBP and DBP were considered independently, 
adherence was significantly different between good and poor controls of SBP 
and DBP. The two groups were positively correlated with SBP control (r= 0.09, p= 0 
.02) and DBP control (r= 0.10, p= 0.01). ConClusions: the Chinese version of the 
MMAS-8 is a reliable and valid measure of medication adherence in Taiwanese 
patients with hypertension.
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objeCtives: The aim of this study was to assess the predictive validity of 
four self-reported measures of adherence on glycemic control measured with 
HbA1c. Methods: A survey conducted to assess factors associated with adherence 
to non-insulin antidiabetes drugs in the Canadian province of Quebec serves as the 
background for the present study. Participants completed an on-line questionnaire 
in which adherence to their treatment was assessed using four self-report instru-
ments: the 4-item and 8-item Morisky Medication Adherence Scales (MMAS-4/8), 
an adaptation of a 5-item scale previously developed to be used with HIV patients 
and a 5-point Likert single item scale developed by our team. A sample of those 
who completed the questionnaire was then asked between 3 and 6 months later to 
measure their HbA1c.   We plotted a receiver operating characteristics (ROC) curve 
for each adherence measure and glycemic control (HbA1c ≤ 7% - > 7%). The predictive 
performance of each instrument was assessed using the area under the ROC curve 
(AUC). AUC ranges from 0 to 1, with 0.5 indicating a no better than chance predic-
tion. Results: A total of 117 participants were studied. Non-stratified analyses 
yielded an AUC of 0.515 (95% CI: 0.423-0.606) for the MMAS-4, 0.532 (0.431-0.633) for 
the MMAS-8, 0.541 (0.452-0.629) for the HIV-adapted scale, and 0.524 (0.441-0.607) 
for our scale. ConClusions: Overall all 4 self-reported measures of adherence 
exhibited a poor validity at predicting glycemic control.
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A valid utility-based self-report measure is essential for evaluating health changes 
in employees. Health utility values permit cost utility analysis to be performed, an 
analytical technique rarely utilised in economic evaluations of workplace health 
promotion. There is no validated health utility measure in working populations. 
objeCtives: To investigate the construct validity of SF-6D health utility instru-
ment in a public service workforce. Methods: The SF-12v2 Health Survey was 
administered to 3409 randomly selected public service employees in Australia in 
2010. SF-12 scores were converted to SF-6D health utility values using Brazier’s 
was 0.14% and 0.10% at 5 years, and 0.74% and 2.55% at 20 years, respectively. When 
using the HK equations, incremental incidences were -0.08% and 0.10% at 5 years 
and -0.27% and -0.18% at 20 years, respectively. ConClusions: Cost-effectiveness 
analyses require accurate estimates of the incremental benefit associated with 
comparator treatments. The UKPDS68 and HK equations did not predict consistent 
incremental event incidences, potentially due to the inclusion of different clinical 
variables as estimators of risk. This highlights the importance of understanding the 
effects of specific risk factors upon the estimation of event incidence, especially 
with respect to different populations.
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objeCtives: Despite the existence of many cost-effective medical and public 
health interventions in prevention and treatment of diabetes, prevalence and cost 
of diabetes are growing in China as well as the rest of world. In order to integrate 
and allocate health system resources to control diabetes successfully, it is neces-
sary to develop dynamic economic evaluation for patient-centered diabetes care 
from a system perspective. Methods: Based on system dynamic (SD) modeling, 
this study develops a framework to depict the structure and feedback loops that 
generate nonlinear relationship between cause and effect in diabetes management. 
It also uses multichannel datasets in China to validate the model and simulate 
the costs and effectiveness of different diabetes management interventions and 
the impact of health insurance policies. Specifically, the framework illustrates a 
patient’s decision making process in physical activities and medication choices and 
their related cost, clinical outcome, and quality of life over time. It also illustrates 
how an individual’s budget constraint, time constraints and health insurance policy 
influence their behaviors. The key stock and flow variables in the model are, direct 
and indirect costs of care, real and perceived risk of diabetes complication, quality 
of life (QoL), financial burdens, and exercise time. Results  And ConClusions: 
The study provides insights on how to evaluate cost and effectiveness of type 2 
diabetes interventions under the complex scenarios of multi-drug taking, switch-
ing drug, and lifestyle changing simultaneously. It suggests that systemic dynamic 
simulations on cost-effectiveness analysis based on real world data can be a new 
vehicle for economic analysis along with RTC trails for decision making. The study 
also builds up a foundation to identify key factors and obstacles in changing patient 
behavior and providing efficient interventions.
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objeCtives: Comparative effectiveness, safety and pharmacoeconomic data are 
required by many health technology assessment agencies to evaluate the relative 
benefits and costs of drugs seeking public reimbursement.  Generally, direct head-
to-head trials are considered the best evidence, whilst non-randomised evidence 
including comparisons of single-arm studies is considered weaker.   In Australia, 
Public Summary Documents (PSDs) report the Pharmaceutical Benefits Advisory 
Committee’s (PBAC) decision-making processes for government reimbursement of 
medicines.  PSDs were reviewed to explore the extent to which single-arm stud-
ies have been used as primary evidence for comparative benefits, their success and 
PBAC’s main concerns with this approach, in Australia. Methods: All PSDs published 
between July 2005 and December 2013 where the primary evidence was reported 
to be single-arm study(s) were reviewed.  Information on the comparator(s), data 
source(s), clinical claim, economic analysis, PBAC concerns and recommendations 
were analysed. Results: Thirteen product submissions met the inclusion criteria.  
Two were for modifications of formulations already reimbursed based on compara-
tive evidence, and were excluded.  In another nine submissions, a single arm of a 
comparative trial was compared with external sources, due to the trial comparator 
not being relevant to the clinical setting. Of the 11 submissions included for review, 
nine used published data to estimate the comparator’s effectiveness and safety.  One 
of these submission also used data from a local observational study.  Three presented 
no comparator data.  Ten submissions claimed superior efficacy and/or safety over 
the comparator.  Six of the 11 products were recommended for reimbursement, of 
which five claimed superiority. Of the five products not recommended, four claimed 
superiority.  Factors associated with a positive recommendation were high clinical 
need or evidence of effectiveness in other indications. ConClusions: While pre-
senting methodological challenges, single arm studies can be used to demonstrate 
robust evidence of superior effectiveness and support recommendations for public 
reimbursement of drugs in Australia.
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objeCtives: Socioeconomic status (SES) is a multidimensional theoretical construct 
that covers a variety of social and financial circumstances. The selection of indica-
tors and their ranking for individual’s classification are of the challenging issues 
in socioeconomic studies. Also integrating different indicators in determining SES 
is usually complex and multidimensional. The aim of this study was to develop a 
model for measuring SES independent of time and place of study. Methods: In 
order to identify proper indicators for determining the SES of individuals, a wide-
spread search was conducted on Pubmed, Embase and Google Scholar. The relevant 
